MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer-Reference-Cited by-同舟云学术

MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer

Published:2016-04-28 Issue:4 Volume:139 Page:890-898
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Abdallah Emne Ali¹,Fanelli Marcello Ferretti²,Souza e Silva Virgílio²,Machado Netto Marcelo Calil²,Gasparini Junior José Luiz¹,Araújo Daniel Vilarim²,Ocea Luciana Menezes Mendonça¹,Buim Marcilei Eliza Cavicchioli¹³,Tariki Milena Shizue²,Alves Vanessa da Silva¹,Piana de Andrade Victor⁴,Dettino Aldo Lourenço Abbade²,Abdon Lopes de Mello Celso²,Chinen Ludmilla Thomé Domingos¹

Affiliation:

1. International Research Center, A.C. Camargo Cancer Center; São Paulo SP Brazil

2. Department of Medical Oncology; A.C. Camargo Cancer Center; São Paulo SP Brazil

3. Department of Health; Universidade Nove de Julho; São Paulo Brazil

4. Department of Anatomical Pathology; A.C. Camargo Cancer Center; São Paulo SP Brazil

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Ferlay J Soerjomataram I Ervik M et al 2013 http://globocan.iarc.fr

2. Circulating tumor cells, disease progression, and survival in metastatic breast cancer;Cristofanilli;N Engl J Med,2004